Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare bill

This article was originally published in The Tan Sheet

Executive Summary

"A prescribed drug or biological product...that is available over-the-counter in addition to being available upon prescription" would be covered by Medicare under legislation introduced April 20 on the Senate and House floors. The clause appears to apply to switch products that still have Rx versions available, such as numerous H2 antagonists. Sen. Edward Kennedy (D-Mass.) introduced the bill (S 841) in the Senate with two cosponsors; the measure was referred to the Finance Committee. Rep. Pete Stark (D-Calif.) introduced the legislation in the House (HR 1495) along with 31 cosponsors; it was referred to the Commerce and Ways & Means Committees
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS089743

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel